Latest / Pharmacy Podcast Network / PSG: Pharmacy Benefits Consulting | TWIRx
Transcript
- 0:00Speaker 1: Hey, it's Lauren Bray Pacheco back with Season three of Symptomatic,
- 0:05Speaker 1: a medical mystery podcast. This season, we're investigating brand new
- 0:08Speaker 1: cases and even revisiting old friends, piecing together the truly
- 0:13Speaker 1: baffling symptoms, and revealing how the quest from medical answers
- 0:17Speaker 1: transforms the lives of everyday people. This is Symptomatic. Listen
- 0:22Speaker 1: to Symptomatic on America's number one podcast network iHeart. Open
- 0:26Speaker 1: your free iHeart app and search Symptomatic and start listening.
- 0:33Speaker 1: You are listening to the global network of podcasters dedicated
- 0:36Speaker 1: to the pharmacy profession.
- 0:38Speaker 2: Welcome to the Pharmacy Podcast Network.
- 1:17Speaker 3: Hey, oh alrighty, then, welcome to a very stressful this
- 1:25Speaker 3: week in pharmacy.
- 1:27Speaker 2: Hold on a second, Oh jeez, I needed that.
- 1:36Speaker 3: Little beverage for the end of this week, the end
- 1:41Speaker 3: of this section of our year of twenty twenty four,
- 1:46Speaker 3: it's been very stressful with the elections. We are going
- 1:49Speaker 3: to do a special election debrief through this week in Pharmacy.
- 1:55Speaker 3: We're going to be doing some mashups and ideas about
- 2:00Speaker 3: where the future of healthcare is going to go, more
- 2:04Speaker 3: specifically pharmacy care. With the acceleration of PBM reform, which
- 2:08Speaker 3: is exciting, but today's episode is special. We are going
- 2:13Speaker 3: to break away from the norm stay away from the
- 2:15Speaker 3: news for a little bit.
- 2:16Speaker 2: Can we just take a break from the news and
- 2:19Speaker 2: stop listening to the news just for a second.
- 2:23Speaker 3: And we're going to welcome Renee Rayberg, who's part of
- 2:27Speaker 3: the PSG Company. That's a research analytics company. They do
- 2:33Speaker 3: audits and clinical optimization, contracting and specialty services. I'm excited
- 2:38Speaker 3: about this interview with Renee and giving us some insights
- 2:41Speaker 3: into the future of where sectors of the pharmaceutical industry
- 2:46Speaker 3: will be going in some of their of her ideas
- 2:49Speaker 3: and their ideas as an organization, and then what that
- 2:54Speaker 3: means for pharmacist opportunities.
- 2:56Speaker 2: We know pharmacy is changing, we know that.
- 3:02Speaker 3: The pharmacist role is expanding, and the MSL opportunities that
- 3:08Speaker 3: pharmacists are going to have out there are pretty significant.
- 3:10Speaker 2: I'm excited about that.
- 3:11Speaker 3: We're going to be doing more interviews about medical science,
- 3:14Speaker 3: liaisons and pharmacists in twenty twenty five. If you want
- 3:17Speaker 3: to get involved, please reach out to me at publisher
- 3:22Speaker 3: at pharmacypodcast dot com. That's publisher at pharmacypodcast dot com.
- 3:27Speaker 3: Make sure that you subscribe, but reach out to us.
- 3:30Speaker 2: Hey.
- 3:31Speaker 3: This episode is brought to you by JB Consulting. These
- 3:35Speaker 3: guys work miracles in the pharmacy technology space, designing software,
- 3:41Speaker 3: designing systems to go between adjudication between your pharmacy management system,
- 3:49Speaker 3: actually customizing data reporting. So we trust in JB Consulting
- 3:55Speaker 3: so much. I met Sean Jensen at a pharmacy conference
- 3:59Speaker 3: and we're moving forward with our own technology back end.
- 4:03Speaker 2: So wait, do you see what's.
- 4:04Speaker 3: Coming in twenty twenty five our from our services that
- 4:10Speaker 3: we're going to be getting through JB Consulting for our
- 4:13Speaker 3: own metrics and our own reporting, and some interesting creative
- 4:18Speaker 3: stuff that's going to be coming from the Pharmacy podcast Network.
- 4:23Speaker 2: And I just want to say thank you.
- 4:26Speaker 3: I want to thank you for how hard you've worked
- 4:28Speaker 3: this year as a pharmacy profession I've seen massive change.
- 4:31Speaker 3: We're going to be talking about hlt H, which is
- 4:34Speaker 3: an innovation conference. We're going to be talking about the NCPA,
- 4:41Speaker 3: the Super Bowl Conference of Independent Community Pharmacy and our
- 4:46Speaker 3: interaction there with your raal Pharma and with real Value
- 4:52Speaker 3: our ex as a secondary wholesaler, and some of their
- 4:55Speaker 3: strategies so I'm excited about what's coming. We're coming. We
- 4:59Speaker 3: are going to be coming in stronger than ever. In
- 5:01Speaker 3: closing out this year, we have a lot of work
- 5:04Speaker 3: to do to prepare. I also want to let you
- 5:06Speaker 3: know Pharmacy fifty is back. It's our fourth annual awards.
- 5:10Speaker 3: I want you all involved. I want you helping us
- 5:12Speaker 3: to share the program to awards someone in our pharmacy
- 5:17Speaker 3: that's making an impact. Once again, this is the fourth
- 5:20Speaker 3: annual Pharmacy fifty, the fifty most influential people in the
- 5:26Speaker 3: profession of pharmacy who are really making a difference in
- 5:29Speaker 3: who are driving the future of pharmacy care, not where
- 5:32Speaker 3: we were ten years ago or twenty years ago. We're
- 5:35Speaker 3: talking about people who have their finger on the pulse,
- 5:39Speaker 3: the bleeding edge, and then the people that are actually
- 5:42Speaker 3: doing it. And we can't wait to see what's going
- 5:45Speaker 3: to come out of our awards this year. It's the
- 5:48Speaker 3: twenty twenty four Pharmacy fifty Awards. It's coming.
- 5:52Speaker 2: We are ready. I want you to hear.
- 5:55Speaker 3: From organizations and people that are truly making a difference
- 6:00Speaker 3: and forwarding our profession. Renee Rayburgh, VP of Clinical Strategy,
- 6:06Speaker 3: I can't wait for you to hear this, hey, and
- 6:08Speaker 3: on this weekend Pharmacy. It's fun to have people in
- 6:12Speaker 3: the studio. I always say, if I make it big,
- 6:15Speaker 3: someday when I grow up, I'm going to have another
- 6:19Speaker 3: studio somewhere with an international airport that is within twenty
- 6:23Speaker 3: minutes of the studio instead of an hour and ten
- 6:25Speaker 3: minutes down here in Brownsville, Pennsylvania, part of the Western
- 6:29Speaker 3: Pennsylvania area. If you know and have been following the
- 6:32Speaker 3: Pharmacy podcast Network, We're in Brownsville and it's a nice
- 6:36Speaker 3: little town, but airport is just too far away. But
- 6:40Speaker 3: sometimes you get pharmaceutical and pharmacy care people that are
- 6:44Speaker 3: from Pittsburgh. Actually, there's a lot of pharmacy people in Pittsburgh.
- 6:48Speaker 3: Did you know that the birthplace of specialty pharmacy was Pittsburgh.
- 6:55Speaker 3: And so with that, I want to welcome my guest today,
- 7:01Speaker 3: Rene Rayberg, to the studio.
- 7:03Speaker 2: It's great to have you here. Thank you. I'm excited
- 7:06Speaker 2: to be here.
- 7:07Speaker 3: Yeah, it's fun to have people in the studio. We
- 7:09Speaker 3: do so much zoom and we do so much stream
- 7:12Speaker 3: yard that it's like virtual fatigue, like I get, you know,
- 7:17Speaker 3: having somebody actually here is just a different environment and
- 7:20Speaker 3: it's fun to just use the studio once in a while.
- 7:23Speaker 4: No, I agree, in person interactions are definitely more valuable.
- 7:26Speaker 3: Yeah, well, all right, So we met through LinkedIn PSG,
- 7:32Speaker 3: and you do so many things that I didn't even
- 7:35Speaker 3: was even like part of our ecosystem. Your intelligence for
- 7:40Speaker 3: the specialty pharmacy sector is the one that fascinated me,
- 7:44Speaker 3: especially things like Genie and soul therapy. And you and
- 7:47Speaker 3: I were both at the last Assembia and didn't even
- 7:50Speaker 3: know it. We're covering so much of the stories of
- 7:53Speaker 3: innovation and specially pharmacy right across from the assembia's main booth.
- 7:57Speaker 3: So we have promised each other to give each other
- 8:00Speaker 3: some time and maybe get a quote from you at
- 8:03Speaker 3: the twenty twenty five ship. Absolutely, yeah, all right, tell
- 8:06Speaker 3: us about PSG, give us an overview of what your
- 8:09Speaker 3: organization is doing.
- 8:11Speaker 4: So at PSG, we are leading pharmacy intelligence and technology
- 8:15Speaker 4: company providing cutting edge drug management strategies and solutions. We
- 8:21Speaker 4: pride ourselves on being independent, So we're independent, but we
- 8:25Speaker 4: relentlessly advocate for our payer clients and helping them navigate
- 8:30Speaker 4: the challenges that they're facing. Right with drug management in
- 8:35Speaker 4: today's industry. So the goal is to deliver, to deliver
- 8:39Speaker 4: actionable solutions and kind of work with them to understand
- 8:43Speaker 4: and meet their needs. And so the niche that we
- 8:46Speaker 4: have is the fact that we use data to drive
- 8:48Speaker 4: a lot of the strategy and solutions that we do.
- 8:52Speaker 4: So we have a software tool called Autometrics that is
- 8:55Speaker 4: where the GENEESQ we'll talk about later sits within, but
- 8:59Speaker 4: Atom houses integrated data, so medical and pharmacy data, and
- 9:03Speaker 4: we're actually able to identify for each client, you know,
- 9:07Speaker 4: what is driving their trend to outli our high cost
- 9:09Speaker 4: claims and things like that. So our staff consists of
- 9:13Speaker 4: seventeen clinical pharmacists, which also I believe is unique. So
- 9:16Speaker 4: we have a strong pulse on the clinical aspects of
- 9:20Speaker 4: pharmacy and drug management. And just to give you an
- 9:24Speaker 4: idea of the type of work that we do, we
- 9:27Speaker 4: did fifty procurements market Chech's renewals last year in twenty
- 9:30Speaker 4: twenty three, over four hundred audits. We have an audit
- 9:33Speaker 4: team as well, we have implementation team too and the
- 9:38Speaker 4: results of all of that hard work was about seven
- 9:40Speaker 4: point two billion in cost savings. So another interesting arm
- 9:44Speaker 4: of our businesses the research arms. So as we were talking,
- 9:47Speaker 4: I'm getting to know each other. We published four different
- 9:51Speaker 4: reports each year, you know, relating from specialty pharmacy, specialty
- 9:57Speaker 4: drug trend and the last one that we published was
- 10:00Speaker 4: is about PBMI satisfaction. I'm sorry, PBM satisfaction.
- 10:05Speaker 2: Yeah, that one was interesting to me.
- 10:06Speaker 3: And we talked about data resources that we've known about.
- 10:11Speaker 3: I've known about for years like drug channels and doctor
- 10:15Speaker 3: fines Team, and you know, your organization is supplying some
- 10:19Speaker 3: of those data points to a lot of organizations that
- 10:22Speaker 3: are drilling down into studies, whether that be PBM. And
- 10:26Speaker 3: if you're watching on YouTube, you'll see the preview of
- 10:29Speaker 3: the twenty twenty four PBM customer Satisfaction Report from PSG.
- 10:34Speaker 3: That's just one example of so many of the things
- 10:37Speaker 3: that you guys are working on and what you're doing.
- 10:39Speaker 3: I think that that's important to this day and age
- 10:41Speaker 3: using it. Data is great. But John NaSTA, I call
- 10:45Speaker 3: him my digital health godfather. He is a philosopher and
- 10:49Speaker 3: speaker across the entire world. He actually goes to big,
- 10:52Speaker 3: big governments and talks to him about what's real and
- 10:55Speaker 3: digital health, and he's like, data is great, but if
- 10:58Speaker 3: you don't, if you can't make sense of it, like
- 11:01Speaker 3: it's not worth anything because it just gets confusing, especially
- 11:04Speaker 3: to I would think like an employer that has a
- 11:07Speaker 3: big HR team that has a benefits team inside it,
- 11:11Speaker 3: and they're like, all right, what do we do with
- 11:13Speaker 3: all this data? It's not making any sense to us?
- 11:16Speaker 3: You know, how do we really drill down into formulary management?
- 11:20Speaker 2: You know what?
- 11:21Speaker 3: And so having a pharmacist insight, which is why I
- 11:24Speaker 3: was excited that you came down, really provides them with
- 11:28Speaker 3: a unique perspective. So talk to us a little bit
- 11:30Speaker 3: about with more of this system. It's called artemax atometrics artometrics. Yeah, yeah,
- 11:36Speaker 3: definitely talk to us about that because I'm fascinated and
- 11:39Speaker 3: I want to ask question. I'm always thinking of when
- 11:42Speaker 3: I sold pharmacy management systems, we always had APIs to
- 11:45Speaker 3: other systems or some integration. So what's the main system
- 11:49Speaker 3: that's being used that someone would use artometrics for.
- 11:54Speaker 4: Well, there's multiple things, but one is just to have
- 11:56Speaker 4: the insight into the integrated data. So to have your
- 12:01Speaker 4: medical drug claims file all your medical claims actually your
- 12:04Speaker 4: pharmacy claims, and your eligibility all together, right, So eligibility
- 12:08Speaker 4: ties the medical and the pharmacy claims and to be
- 12:11Speaker 4: able to in one system to look at what's driving
- 12:14Speaker 4: your trend. You know, what is specific as a patient
- 12:19Speaker 4: level data to understand you know, the different patients their
- 12:23Speaker 4: claims history.
- 12:24Speaker 2: You know, we have the.
- 12:26Speaker 4: Ties to the medical data, so we have encounter information
- 12:29Speaker 4: so you can see. So if you're looking at patient
- 12:32Speaker 4: that's on a specific MS drug and you're spending a
- 12:34Speaker 4: lot of money on that drug, you want to get
- 12:36Speaker 4: an idea is it working for the patient?
- 12:38Speaker 3: Right?
- 12:38Speaker 4: How's the patient doing? We can go and see, you know,
- 12:41Speaker 4: have they been to the er lately, have they been
- 12:43Speaker 4: in the hospital. You know, we can track their you know,
- 12:45Speaker 4: kind of their medical encounters. We actually have a total
- 12:49Speaker 4: cost of claim function in there that looks at too,
- 12:51Speaker 4: you know, that measures them against all the other patients
- 12:53Speaker 4: that have MS in that population. But data is important, right,
- 12:58Speaker 4: but how you organize it and how you use it
- 13:01Speaker 4: becomes even more important. And we have saying i'd say
- 13:04Speaker 4: all the time.
- 13:05Speaker 2: Is this so what?
- 13:06Speaker 4: And that's what really we're trying to find, right, So
- 13:08Speaker 4: we don't want to sit there and tell you, oh,
- 13:11Speaker 4: guess what humor was your number one drug spend for
- 13:13Speaker 4: the last ten years, right, So what is you know,
- 13:16Speaker 4: what can we do about it? Why do I need
- 13:18Speaker 4: to know this? Why is it important to me to
- 13:21Speaker 4: know that information? And that's really what we try to
- 13:23Speaker 4: dig into and that's where the actionable solutions come in. So,
- 13:27Speaker 4: you know, did you know that you know you had
- 13:30Speaker 4: this high cost claim as an outlier? We've found so
- 13:33Speaker 4: many through the data to say, you know, just recently
- 13:36Speaker 4: found a person that was getting probably three times what
- 13:40Speaker 4: they should have gotten in the quantity for a specialty drugs.
- 13:43Speaker 4: So the claim was over one hundred thousand dollars. It
- 13:45Speaker 4: turned out that they had a quantity limit in place,
- 13:48Speaker 4: so apparently it must not have been coded correctly. So
- 13:51Speaker 4: you know, identifying that information, then taking it to the
- 13:54Speaker 4: PBM on their behalf and then finding out kind of
- 13:57Speaker 4: what happens, right, and so how do you correct it
- 13:59Speaker 4: and mitigate other outlier claims?
- 14:02Speaker 3: Things like that, who's who's the physical user of artrometrics?
- 14:07Speaker 4: Like how great? Yeah, great question. Uh, it can be
- 14:11Speaker 4: a pharmacist, right, it could be pharmacy. So for health plans,
- 14:13Speaker 4: it's usually a typical pharmacy director. The pharmacists that are working,
- 14:17Speaker 4: but it also could be the analytics team as well,
- 14:19Speaker 4: and so we have employers that also use artometrics, and
- 14:22Speaker 4: so we have their financial analysts that are using it.
- 14:24Speaker 4: There we have a client where the CFO actually gets
- 14:28Speaker 4: in there and looks at it, right the you know,
- 14:30Speaker 4: the HR benefit director. So it just depends on how
- 14:34Speaker 4: the organizations are set up and if they have the
- 14:37Speaker 4: resources to do the work. Much of the work is
- 14:40Speaker 4: us doing it on their behalf. So it's just as
- 14:43Speaker 4: valuable from the aspect as well.
- 14:44Speaker 3: Remember you and I before we start recording, we're talking
- 14:47Speaker 3: about so we know the big huge conglomerate big PBMs.
- 14:51Speaker 3: Then they're whatever they're gonna They're going to get the
- 14:54Speaker 3: old shakedown now. But there's a whole bunch of other
- 14:57Speaker 3: PBMs that are privately owned carve out type of benefits
- 15:00Speaker 3: standings that are just amazing organizations. I shout out to
- 15:04Speaker 3: the Fields family out of Ohio who started appro RX
- 15:07Speaker 3: and Capital RX and truth are I mean, no, I
- 15:12Speaker 3: can't remember the other one that's a transparency one, but
- 15:15Speaker 3: True Benefits I think anyway, so I'm fascinated to think, Okay,
- 15:20Speaker 3: where are they getting their data? And what tools are
- 15:23Speaker 3: they dialing into to really get more out of the
- 15:27Speaker 3: claims data and the follow up and what's coming and
- 15:31Speaker 3: drug pricing and so is archimetrics arto metrics.
- 15:35Speaker 2: Are you guys helping them too?
- 15:37Speaker 4: So in some cases yes, because I think vertical integration
- 15:42Speaker 4: has been long talked about, right, but I would venture
- 15:45Speaker 4: to say, just Renee's opinion, it's not being done all
- 15:48Speaker 4: that well, especially at the biggest levels. And so the
- 15:53Speaker 4: fact that we can put the pharmacy claims data and
- 15:55Speaker 4: the medical claims data together and to look at it
- 15:58Speaker 4: together always one, I think is the most valuable piece
- 16:00Speaker 4: of that. So, but where it is helpful is it
- 16:04Speaker 4: can be used as a reporting tool. So we have
- 16:07Speaker 4: ways to generate quarterly data reports, you know, things like
- 16:12Speaker 4: that that can show we have a hierarchy build so
- 16:15Speaker 4: that you know, if even for health plans, if you
- 16:17Speaker 4: have different ASO clients that you can get specific drilled
- 16:21Speaker 4: down to that client level the same you know, amount
- 16:24Speaker 4: of data things like that. So but from a reporting perspective,
- 16:28Speaker 4: I think it is really helpful and we can help.
- 16:30Speaker 4: So just as an example, with the clients that I
- 16:33Speaker 4: work with, I have access to the medical data so
- 16:35Speaker 4: when we're on a quarterly PBM call, we may be
- 16:38Speaker 4: discussing a drug and a drug spend. Like I actually
- 16:41Speaker 4: can look it up and see, okay, for every you
- 16:44Speaker 4: know member that's using depicts, and I could tell you
- 16:46Speaker 4: how many of them are using it for a topic dermatitis,
- 16:48Speaker 4: or how many of them are using it for asthma,
- 16:51Speaker 4: So just through a couple of clicks. So there's value
- 16:54Speaker 4: in that sense as well.
- 16:55Speaker 3: How where you are you you're obviously extracting CP t
- 17:01Speaker 3: ICD tens all from electronic health records. Do you have
- 17:05Speaker 3: interfaces to all of these big systems.
- 17:08Speaker 4: They come through in a medical claims file and I
- 17:11Speaker 4: am technology is not my strong suit, so so but
- 17:14Speaker 4: it's medical claims file is sent over and then we
- 17:19Speaker 4: have experts within our data team that ingest the data
- 17:22Speaker 4: and transform it to be able to put it within
- 17:25Speaker 4: the tool and get it to the working level that
- 17:27Speaker 4: we need.
- 17:28Speaker 3: I haven't sold pharmacy software in nearly ten years, but
- 17:33Speaker 3: I remember a file, a file called the eight fifty
- 17:35Speaker 3: six which was like a claim file that had specific
- 17:39Speaker 3: metrics in it. I don't know if it's that one,
- 17:41Speaker 3: but obviously it's like a big data dump to your
- 17:43Speaker 3: system and then your system demystifies it and kind of
- 17:47Speaker 3: organizes it and brings it to light.
- 17:50Speaker 4: Nowally, yeah, the data transformation is where the magic happens.
- 17:53Speaker 2: Right with our team?
- 17:54Speaker 3: Yeah yeah, data is great, but if you can't use it,
- 17:57Speaker 3: what's the purpose?
- 17:58Speaker 2: Right?
- 17:58Speaker 3: This is because this is going to be more important
- 18:02Speaker 3: in the EVE. And you have your opinion, and I
- 18:05Speaker 3: always have my opinion. Everybody listening has an opinion. But
- 18:08Speaker 3: my opinion for years, and I'm putting my foot down
- 18:12Speaker 3: for twenty twenty five is the rise of the pharmacist.
- 18:16Speaker 2: And here's the reason.
- 18:18Speaker 3: A couple sociological issues and economic issues. And one of
- 18:22Speaker 3: those economic issues is is we're minus eight thousand pharmacies
- 18:27Speaker 3: right now that we're here two and three years ago
- 18:29Speaker 3: that aren't here anymore. So pharmacy deserts are going to
- 18:32Speaker 3: impact public health, and the pharmacies that are out there
- 18:36Speaker 3: are going to have to become strengthened in order to
- 18:39Speaker 3: continue to provide at least some sort of healthcare service
- 18:43Speaker 3: in an area where some people have to drive twenty
- 18:45Speaker 3: thirty sometimes forty miles to get care, or they don't
- 18:49Speaker 3: have any public transportation and their pharmacy used to be
- 18:53Speaker 3: a two mile bus ride and now it's a twenty
- 18:56Speaker 3: mile uber or ride, which is never going to happen.
- 18:59Speaker 3: So we have technology partners, we have independent pharmacy networks,
- 19:04Speaker 3: we have buying groups who are all working together to
- 19:07Speaker 3: get the most out of everything to try to soak
- 19:12Speaker 3: up some of the pharmacy desert pockets.
- 19:15Speaker 2: And data is going to play.
- 19:16Speaker 3: A big, big, huge part of that, and your organization,
- 19:20Speaker 3: I'll guarantee, is going to probably see some growth because
- 19:24Speaker 3: the money being spent now is going to be scrutinized
- 19:28Speaker 3: at levels that we've never seen from an audit perspective.
- 19:31Speaker 3: Because a lot of the I call it truth, whereas
- 19:35Speaker 3: some people might aren't. Pcma might say something else. But
- 19:38Speaker 3: when the truth comes out about all of the profit
- 19:41Speaker 3: that was all about just that and not about healthcare
- 19:45Speaker 3: through Medicaid and Medicare and some of the other government
- 19:50Speaker 3: run plans, I don't mind so much.
- 19:53Speaker 2: I mean I do mind.
- 19:54Speaker 3: But if you get taken advantage of and you're on
- 19:57Speaker 3: a private.
- 19:57Speaker 2: Insurance plan, that's one thing.
- 20:00Speaker 3: But if your grandma and you don't have any money
- 20:03Speaker 3: and you're relying on Medicaid to give you your life
- 20:07Speaker 3: saving medication, and now you can't afford it because the
- 20:12Speaker 3: big PBMs are sucking up all the mustard and sauce
- 20:15Speaker 3: and keeping it to themselves. That's where I become anti.
- 20:20Speaker 3: I don't know if that's partial anti. Maybe I'm a
- 20:23Speaker 3: reasonable capitalist because I love capitalism, but I don't like
- 20:27Speaker 3: it at that.
- 20:27Speaker 2: Level where it starts crushing people's well being.
- 20:30Speaker 4: Correct. So it is a business, and I respect that, right.
- 20:33Speaker 4: It's a business for all the players, right. But at
- 20:39Speaker 4: the same time, I think there's a finite number of
- 20:42Speaker 4: healthcare dollars available, so we want to spend that in
- 20:45Speaker 4: the best way possible. And that's where the data really
- 20:48Speaker 4: comes in. So you know, we find instances of these
- 20:52Speaker 4: high cost outlier claims and sometimes it's a simple fix, right.
- 20:55Speaker 4: Sometimes it could be a fat finger, right, a fat
- 20:57Speaker 4: finger with a specialty drug could result in a lot
- 21:00Speaker 4: of money, right. But sometimes it's just awareness, right, and
- 21:03Speaker 4: awareness that you know these drugs are being used in
- 21:07Speaker 4: this way or overuse or misuse. And when you marry
- 21:10Speaker 4: that with the clinical pieces and the evidence to support it,
- 21:16Speaker 4: it becomes even more valuable. And I think that that
- 21:18Speaker 4: is something special we do at PhD because we could
- 21:22Speaker 4: take that data and we make recommendations, and there's nothing
- 21:25Speaker 4: more satisfying than, you know, when we make a recommendation
- 21:28Speaker 4: to put a quantity limit or utilization management in place
- 21:31Speaker 4: and then we see an article pop up that validates
- 21:33Speaker 4: exactly why we put that in place. And that has
- 21:36Speaker 4: happened recently a couple of times in the past two weeks,
- 21:40Speaker 4: where it just you know, it's strengthens kind of the
- 21:43Speaker 4: work that we do. But at the end of the day,
- 21:46Speaker 4: there's a finite number of healthcare dollars, so and every
- 21:49Speaker 4: peny accounts. I said that once on a PBM call,
- 21:51Speaker 4: and I'm not sure everyone from the PBM side agreed
- 21:53Speaker 4: with me, but truly, you know, the payers that we
- 21:57Speaker 4: work with, and you know, they act like it's their
- 22:00Speaker 4: money because that's how meaningful it is to their organization
- 22:03Speaker 4: to be able to continue to provide those benefits and such.
- 22:06Speaker 3: YEA, all right, well, Renee, we've enjoyed having you here.
- 22:10Speaker 3: We'd like to have PSG back on future episodes and
- 22:13Speaker 3: really drill down into maybe some disease state specific data
- 22:17Speaker 3: and kind of getting some ecology pharmacies and pharmacists involved,
- 22:21Speaker 3: or dialing into pediatrics or something. But I think there's
- 22:24Speaker 3: a lot that we could do together in twenty twenty five,
- 22:26Speaker 3: So I look forward to following up with you.
- 22:29Speaker 2: Yeah, thank you. This is great.
- 22:30Speaker 3: Yeah, all right, we'll be back back with more from
- 22:34Speaker 3: this weekend Pharmacy. Stay tuned and listen to this message.
- 22:39Speaker 3: This is one of our sponsors.
- 22:40Speaker 2: Thank you.
- 22:49Speaker 5: This episode is sponsored by Independent Pharmacy Cooperative, widely known
- 22:53Speaker 5: as IPC. Established in nineteen eighty three, IPC is the
- 22:56Speaker 5: nation's largest group purchasing organization owned by a dependent pharmacy
- 23:01Speaker 5: with a mission of maximizing the success of community pharmacists.
- 23:04Speaker 5: IPC works to provide members with access to effective programs
- 23:08Speaker 5: and services designed to enhance profitability for independent pharmacy. Read
- 23:13Speaker 5: more about our mission by checking out our website at
- 23:15Speaker 5: ipcrx dot com. That's ipcrx dot com.
- 23:31Speaker 3: Hey, head on over to Jbconsulting dot com. This is
- 23:36Speaker 3: a group that is committed to our profession, the pharmacy profession.
- 23:40Speaker 3: We kind of met Sean Jensen at a specialty pharmacy conference,
- 23:46Speaker 3: but Sean, you really work in electronic health records. You
- 23:49Speaker 3: work with other facets of the pharmaceutical industry. Give us
- 23:52Speaker 3: a quick overview of JB Consulting.
- 23:55Speaker 6: So yea, we work with everybody in the specialty pharmacy industry.
- 23:58Speaker 6: We help companies to get more with technology, get more
- 24:02Speaker 6: out of their teams using technology, We help connect systems,
- 24:05Speaker 6: and we help get more insights out of data and
- 24:08Speaker 6: enhance the data capabilities of our customers.
- 24:11Speaker 2: That's excellent.
- 24:12Speaker 3: So a JB Consulting, you've been around for twenty years.
- 24:16Speaker 3: I've seen case studies that you've worked on, which is
- 24:20Speaker 3: really interesting, especially pharmacy case study that you worked on
- 24:23Speaker 3: with NCPDP. Talk to us a little bit about things
- 24:26Speaker 3: that you've done specifically in specialty.
- 24:29Speaker 6: I mean just connecting systems and connecting different organizations is
- 24:33Speaker 6: a huge one. And then working with all the different data.
- 24:36Speaker 6: I mean you get certain data out of a pharmacy system,
- 24:38Speaker 6: but there's just so much more for specialty that we
- 24:40Speaker 6: really help our customers improve that data capability that otherwise
- 24:44Speaker 6: wouldn't have.
- 24:45Speaker 3: YEP, integration with electronic health records, special needs, artificial intelligence.
- 24:52Speaker 3: I want everyone to go over to Jbconsulting dot com
- 24:56Speaker 3: and take a look once again it's Jbconsulting dot com,
- 25:00Speaker 3: and reach out to Sean Jensen, tell them you heard
- 25:03Speaker 3: this on Pharmacy Podcast Network and Sean, we will be
- 25:07Speaker 3: seeing you soon at upcoming meetings.
- 25:10Speaker 6: Sounds great, Thanks don.
- 25:15Speaker 3: Alrighty, then, hey, this Week in Pharmacy has really been
- 25:20Speaker 3: special to me. It's my first it's actually my first
- 25:23Speaker 3: podcast that is specifically kind of a catch all, a
- 25:30Speaker 3: catch all audio program for our profession. So a lot
- 25:35Speaker 3: of that creativity comes from you. I've had so many
- 25:37Speaker 3: listeners start getting involved in our programming. So if you're
- 25:40Speaker 3: listening right now and you're digging into something specific pediatrics,
- 25:47Speaker 3: if you're digging into HIV, if you're digging into oncology, whatever,
- 25:51Speaker 3: it is just like blogging, just like if you go
- 25:54Speaker 3: to media Medium or you go to some other blogging site.
- 25:59Speaker 3: Speaking of bla blogging sites. Before I go any further,
- 26:02Speaker 3: Medical Life. Have you heard of Medica Life. If you haven't,
- 26:06Speaker 3: I want you to look up Medical Life. It's Medika
- 26:12Speaker 3: dot Life. Once again, that's Medica Life. We have a
- 26:17Speaker 3: partnership with them when we're taking pharmacy insights and we're
- 26:21Speaker 3: helping to promote those insights. I like building it into
- 26:24Speaker 3: podcasting and then push it over to Medical Life for
- 26:27Speaker 3: the text in the traditional blogging, which is very important,
- 26:32Speaker 3: and Medica has three hundred thousand plus sometimes depending on
- 26:38Speaker 3: their thing, I think it's a million readers that come
- 26:40Speaker 3: to their content and they're all primarily healthcare professionals in
- 26:47Speaker 3: some capacity.
- 26:48Speaker 2: So that kind of.
- 26:48Speaker 3: Connection is part of the future of this publication and
- 26:53Speaker 3: of this network that is growing at a global scale,
- 26:57Speaker 3: and we're plugging pharmacists into each other and you're doing
- 27:00Speaker 3: projects all on your own, and that's what really this
- 27:03Speaker 3: is about. We are excited about the APHA twenty twenty five.
- 27:08Speaker 3: I can't tell you how excited I am that this
- 27:11Speaker 3: is going to be a supercharged event because of how
- 27:14Speaker 3: much momentum that we're picking up, because of the evolution
- 27:21Speaker 3: of our profession and how pharmacists are leading, and how
- 27:26Speaker 3: this is just a time to celebrate.
- 27:30Speaker 4: So you will.
- 27:36Speaker 3: Benefit from that gathering and that coming together more than ever,
- 27:42Speaker 3: just because of the focus that we're going to have
- 27:44Speaker 3: on we'd like to actually have very specific content that
- 27:48Speaker 3: we'll be covering. A lot of that content comes from
- 27:52Speaker 3: our hosts. In a shout out to all of our
- 27:55Speaker 3: hosts that have given us content over the last fifteen
- 27:58Speaker 3: and a half years, I want to give a shout
- 28:02Speaker 3: out to a guy named Matthew Zachary. Matthew Zachary was
- 28:07Speaker 3: a pioneer in podcasting. I don't know how long ago
- 28:11Speaker 3: it was, but it was before we started. I started
- 28:13Speaker 3: in two thousand and nine, so I think he started
- 28:16Speaker 3: in podcasting started in two thousand and six, so he
- 28:19Speaker 3: was definitely before that. And he was going through my Space.
- 28:24Speaker 3: That's going to age him right there. As soon as
- 28:26Speaker 3: you say my Space, it's just like, Yo, are you
- 28:30Speaker 3: a boomer or are you gen x?
- 28:32Speaker 2: Or what's up?
- 28:33Speaker 3: It's probably pretty much gen x. He's Matthew, I would guess,
- 28:36Speaker 3: is my age. And he's very special to me, a
- 28:41Speaker 3: very special friend that's kind of educated me to the
- 28:44Speaker 3: importance of being real with your patients and being a
- 28:50Speaker 3: human to your patients and stop sugar coating it and
- 28:53Speaker 3: stop being fake and using funds for the right way.
- 28:57Speaker 3: But he has really been special over the years of
- 29:02Speaker 3: educating me. He posted something on LinkedIn that he got
- 29:06Speaker 3: to spend time with us at the studio. It's a
- 29:09Speaker 3: special episode that's out on our YouTube page. I got
- 29:13Speaker 3: to have him in the studio. It was an amazing conversation.
- 29:17Speaker 3: It was a very raw conversation. There's uh, there's there's
- 29:23Speaker 3: emotion in this conversation, and there's education in it. So
- 29:27Speaker 3: I want you to take advantage of this. I want
- 29:30Speaker 3: you to listen to. It's titled healthcare Isn't Broken. It
- 29:34Speaker 3: was built this way. So the title of his article
- 29:38Speaker 3: health care Isn't broken, it was built this way. And
- 29:41Speaker 3: he just goes through the truth from his perspective as
- 29:45Speaker 3: a patient that that got cancer thought. You know when
- 29:49Speaker 3: you say cancer, my goodness, gracious, I can only imagine
- 29:53Speaker 3: what you go through. Some of your listeners out there,
- 29:55Speaker 3: you've gone through it, so you know exactly what that
- 29:58Speaker 3: what that felt like getting that announcement, But that announcement,
- 30:02Speaker 3: and then how the system he realized as a cancer patient,
- 30:07Speaker 3: how he would say fed up it is, except he
- 30:10Speaker 3: would of course say the f U c K, which
- 30:12Speaker 3: if you listen to this interview, he does drop all
- 30:15Speaker 3: the bombs because it's real. I wanted it to be raw.
- 30:18Speaker 3: I wanted to be for real. So what did he
- 30:21Speaker 3: go through as a patient in in cancer care? You're
- 30:25Speaker 3: listening right now, are you a cancer focused pharmacist? If
- 30:29Speaker 3: the answer is yes, listen to this interview with Matthew Zachary.
- 30:33Speaker 3: Go to LinkedIn look up Matthew Zachary, look up this
- 30:37Speaker 3: post of him talking about his experience telling his story
- 30:42Speaker 3: about pharmacists.
- 30:43Speaker 2: You're gonna You're gonna be very I.
- 30:46Speaker 3: Opened when you listen to this interview, and I want
- 30:50Speaker 3: you to take advantage of this time too, to learn
- 30:53Speaker 3: from Matthew and realize that we need more patients that
- 31:00Speaker 3: are telling the stories of what's really happening from their experience,
- 31:05Speaker 3: and the bad experiences are not coming from the provider
- 31:09Speaker 3: themselves most of the time. You know, I can't say
- 31:14Speaker 3: that overall, but most of the time, it's not the provider.
- 31:17Speaker 3: It's not the pharmacist, it's not the nurse, it's not
- 31:19Speaker 3: the physician.
- 31:21Speaker 2: It's the system.
- 31:22Speaker 3: It's the system around them that is kept them hostage
- 31:28Speaker 3: from receiving the healthcare that they want. And you know,
- 31:30Speaker 3: as well as I do listening to us right now,
- 31:33Speaker 3: what the PBMs have done to our profession, and they're
- 31:37Speaker 3: healing and we're healing, and they're transforming, they're going to
- 31:40Speaker 3: have to change. And not that they're not invited anymore
- 31:42Speaker 3: as long as they're paying a pharmacist for what they're worth.
- 31:45Speaker 3: And the reimbursement and stop playing games and stop with
- 31:49Speaker 3: the spread pricing. And you know what, if a pharmacist
- 31:54Speaker 3: is involved, they should be leading the clinical care. Obviously,
- 32:00Speaker 3: any insurance organization that is making a payment should not
- 32:05Speaker 3: own pharmacies. So a PBM should absolutely not be able
- 32:10Speaker 3: to own pharmacies because it's a conflict of interest. And
- 32:13Speaker 3: if you gathered up all of the independent community pharmacies
- 32:15Speaker 3: in the United States and you had them start working
- 32:19Speaker 3: on their own insurance program, you know as well as
- 32:21Speaker 3: I do, you'd get flagged by every major federal Association
- 32:28Speaker 3: protection agency of our big government. You definitely flag their attention.
- 32:33Speaker 3: And if FTC would say, no, you can't do this,
- 32:36Speaker 3: it's a collusion, and I'm just like, okay, then then
- 32:40Speaker 3: what is it when big, big corporations do it? You
- 32:43Speaker 3: know them right, you know, you know exactly what we're
- 32:46Speaker 3: talking about. By the way, PBM Reform podcast go google
- 32:50Speaker 3: PBM reform podcasts. As part of our network, we have
- 32:54Speaker 3: so much content there educating about PBM reform.
- 32:57Speaker 2: So if you have someone that.
- 32:58Speaker 3: Doesn't understand it, go out and find a couple of
- 33:01Speaker 3: those episodes. Many of the people in there have contributed
- 33:05Speaker 3: that have different insights in what that means, what PBM
- 33:09Speaker 3: reform truly means, and if it should even be reformed.
- 33:12Speaker 3: There have been people that we talk to, people that
- 33:16Speaker 3: are transforming pharmacy care, the cash based system pharmacies that
- 33:20Speaker 3: are out there that they're like, hey, just remove the
- 33:24Speaker 3: PBM altogether. And with other countries doing what they're doing
- 33:28Speaker 3: in medication care, is that another option? Is that the future?
- 33:34Speaker 3: But guess what, it's not staying the same. It's not
- 33:38Speaker 3: staying the same. That means that you're going to have
- 33:40Speaker 3: more opportunity as an individual pharmacist, an individual pharmacist inside
- 33:46Speaker 3: of community pharmacy, the individual expertise pharmacist inside a specific
- 33:52Speaker 3: disease state. The Board of Specialties will be expanding. These
- 33:58Speaker 3: Board of Specialties will include pharmacogenomics as a specialty, pain
- 34:03Speaker 3: care as a specialty. I actually know that as inside
- 34:06Speaker 3: information from doctor Gary Fully from the WVU School of Pharmacy.
- 34:11Speaker 3: Shout out to the.
- 34:12Speaker 2: Pain guy hashtag pain guy.
- 34:16Speaker 3: Mark knows what's up and he knows that the Board
- 34:20Speaker 3: of Specialties will be expanding. That means that your expertise
- 34:24Speaker 3: as a clinical pharmacist digging deep into a specific condition,
- 34:28Speaker 3: your insights are going to be worth something. They are
- 34:31Speaker 3: worth something. Well, who's marketing you? Who is marketing you?
- 34:37Speaker 3: Are you marketing yourself? It's a lot of work and
- 34:40Speaker 3: good luck getting banned with doing it. Hey, they're out there.
- 34:44Speaker 3: There's plenty of onesie twosie pharmacists who have journeyed out
- 34:48Speaker 3: in the realm of building themselves a brand, and it's
- 34:52Speaker 3: some of them is working. I mean, some of them
- 34:54Speaker 3: are superstars and it's working. However, there are some of
- 34:58Speaker 3: you who are just as and just as intelligent as
- 35:02Speaker 3: providers as pharmacists, who are digging down into disease states
- 35:05Speaker 3: and nutrition and specific diseases and diabetes management and weight
- 35:11Speaker 3: loss management and the whole thing. And you want to
- 35:14Speaker 3: build a business, right and you want an organization that
- 35:19Speaker 3: you could partner with to understand what you're trying to do,
- 35:23Speaker 3: knows your vernacular, knows how to market you, has the
- 35:25Speaker 3: network to market you. We're looking at doing some major
- 35:30Speaker 3: major changes in twenty twenty five to support pharmacy professionals,
- 35:35Speaker 3: but we only want serious pharmacist professionals entrepreneurs that are
- 35:40Speaker 3: ready to build sales, business development, and marketing infrastructure underneath
- 35:46Speaker 3: you and around you and surround you like an agency,
- 35:50Speaker 3: which is that's exactly what it's going to become, where
- 35:53Speaker 3: we can say, hey, what do you want to do?
- 35:56Speaker 3: Are you into sickle cell pain management? Are you in
- 35:59Speaker 3: care annabis pharmacy? Are you building your remote patient monitoring services?
- 36:05Speaker 2: Right? I mean that's happening.
- 36:09Speaker 3: Thea blistone doctor blistone up in Meadville, Pennsylvania is building
- 36:13Speaker 3: an entire consultancy around patient remote patient monitoring services and
- 36:19Speaker 3: remote pharmacy services and getting paid and getting other pharmacists
- 36:25Speaker 3: paid and there. I mean, this is going to become
- 36:28Speaker 3: their this is going to become their full time job.
- 36:31Speaker 3: They're going to make all the money that you should
- 36:33Speaker 3: be making as a pharmacist and sometimes more. And we
- 36:36Speaker 3: are going to back them up marketing, business development, contract management, negotiation, salesforce.
- 36:45Speaker 3: I can't wait. It's a whole other level. It's time
- 36:48Speaker 3: to evolve. We're evolving. You're evolving. Pharmacy technicians are evolving.
- 36:54Speaker 3: Shout out to Mike Johnston from the NPTA, the National
- 36:58Speaker 3: Pharmacy Technician Association. They're now part of the network. We're strengthening.
- 37:03Speaker 3: We see the strengthening of our profession taking back control
- 37:07Speaker 3: of it, and it's going to be one of the
- 37:10Speaker 3: most different years in our profession than you've ever seen.
- 37:14Speaker 2: Of what you're about to see in twenty twenty five.
- 37:16Speaker 3: We also hear some tricklings and some whispers in digital
- 37:21Speaker 3: therapeutics and our new show, our new host which is
- 37:26Speaker 3: going to be announced coming very soon for Digital therapeut Talks,
- 37:31Speaker 3: which is the podcast all about digital therapeutics. There's a
- 37:34Speaker 3: lot happening in that market, and there's finally FDA approval
- 37:39Speaker 3: of different apps for different conditions based on the same proven,
- 37:44Speaker 3: evidence based method of storing information and using information and
- 37:50Speaker 3: then giving that information back to the clinicians, back to
- 37:53Speaker 3: your physician and pharmacists and therapists to dial into behavioral health.
- 38:00Speaker 3: That is a major future for the future of pharmacists
- 38:05Speaker 3: and I am excited that we get to be a
- 38:08Speaker 3: part of it. And thank you for allowing us to
- 38:10Speaker 3: be a podcast network for you to listen to to
- 38:15Speaker 3: really advocate for you as the medication professional. If you're
- 38:20Speaker 3: listening to this show and you have a podcast idea,
- 38:24Speaker 3: if you're thinking about podcasting, we have resources for training you,
- 38:28Speaker 3: we have resources for getting you started. We have resources
- 38:32Speaker 3: for best equipment to use, just come to us. And
- 38:36Speaker 3: then if you want to take it to the next
- 38:37Speaker 3: level where you actually start making money from your podcast,
- 38:41Speaker 3: that's a whole other level of service that is going
- 38:43Speaker 3: to be offered.
- 38:44Speaker 2: But just let's let me say this.
- 38:46Speaker 3: Content developers are a big future for our healthcare profession
- 38:53Speaker 3: because of the acceleration of social media, acceleration of TikTok,
- 38:57Speaker 3: the acceleration of information trust.
- 39:02Speaker 2: Guess what, podcasts.
- 39:05Speaker 3: I don't want to say the word, but I'm going
- 39:06Speaker 3: to say it one more time, and I promise I
- 39:07Speaker 3: won't say it anymore. Podcasts impacted the election. That's the
- 39:13Speaker 3: bad word of the day. Election Election twenty twenty four.
- 39:18Speaker 3: Election twenty twenty four at the local, at the state,
- 39:23Speaker 3: and at the federal level was actually impacted by podcasting.
- 39:28Speaker 3: And we've been sitting around and standing around and running
- 39:31Speaker 3: around and jumping around for almost sixteen years now. And
- 39:35Speaker 3: now it's time to take it up another level. It's
- 39:38Speaker 3: time for us to partner with bigger organizations, which we
- 39:42Speaker 3: already have in place.
- 39:44Speaker 2: iHeartMedia.
- 39:45Speaker 3: iHeartMedia's Ruby division has a podcast episode. They have a
- 39:51Speaker 3: podcast out called Symptomatic, and Symptomatic is a medical mystery
- 39:58Speaker 3: podcast which I I love that medical mystery podcast, and
- 40:03Speaker 3: they are looking to us to get pharmacists to dial
- 40:09Speaker 3: into some of the conditions that they're talking about and
- 40:14Speaker 3: giving their opinion from a pharmacist perspective, which is going
- 40:18Speaker 3: to open the door for more opportunity for exposure of
- 40:22Speaker 3: pharmacist insight through iHeart. And they're the biggest podcast distributor,
- 40:30Speaker 3: not hosting provider, but distributor in the world for podcasting,
- 40:34Speaker 3: and it's just amazing to be to be part a small,
- 40:38Speaker 3: tiny part of getting out the messaging. So this is
- 40:41Speaker 3: a fun podcasts It's called Symptomatic. You can find it
- 40:45Speaker 3: on any podcast player, but you can also go to
- 40:48Speaker 3: iHeart dot com and as you see on the screen
- 40:51Speaker 3: right here, if you're watching YouTube, go to Symptomatic listen
- 40:55Speaker 3: to these episodes. They have up to twenty one cases
- 40:58Speaker 3: right now, but you only have to go through twenty
- 41:00Speaker 3: one twenty nineteen for episode or season three. So we're
- 41:08Speaker 3: going to have on November twelfth, we're going to have
- 41:11Speaker 3: a live discussion on Symptomatic and we're going to have
- 41:16Speaker 3: a five panel process people processes discussion about these conditions
- 41:25Speaker 3: and be able to get the insights of pharmacists on
- 41:30Speaker 3: some of the strangest descriptions of what patients were going through.
- 41:35Speaker 3: It's like I said, it's a mystery and you have
- 41:37Speaker 3: to be able to kind of listen in to the
- 41:40Speaker 3: description of the actual patients testimony of what they were
- 41:44Speaker 3: going through, what they thought they were going through, many
- 41:47Speaker 3: times thinking, you know, am I dying? And the terror
- 41:51Speaker 3: that they were probably going through, and then you figuring
- 41:55Speaker 3: out along the way as the medication experts, guessing what
- 42:01Speaker 3: condition did you think that the patient was describing and
- 42:06Speaker 3: what medications would have been involved, and can we give
- 42:10Speaker 3: feedback to big publishers and big organizations that listen back
- 42:16Speaker 3: to pharmacist insights and realizing that while have we underplayed
- 42:21Speaker 3: the position of our pharmacists and what they know.
- 42:27Speaker 2: So it's exciting.
- 42:28Speaker 3: We're going to have a panel of pharmacists as well
- 42:31Speaker 3: as business professionals talk about the Symptomatic coming on November
- 42:38Speaker 3: twelfth next week, and it'll be at six pm live.
- 42:43Speaker 3: It'll be a live discussion with doctor Ryan Paul Steven Beckman,
- 42:48Speaker 3: who is CEO of Ural Pharma, doctor Mark Garafole, the
- 42:55Speaker 3: Pain Guy, hashtag pain Guy. Shout out to Mark, doctor
- 43:01Speaker 3: Tamar Lawful. She's one of our podcasts hosts, as is
- 43:06Speaker 3: Mark garra Foley and myself, and we'll have doctor Becky
- 43:12Speaker 3: Winslow on as well from the very well known PGC
- 43:17Speaker 3: focused podcast that she co hosts with benaz Sarami. So Becky, Stephen, Ryan,
- 43:23Speaker 3: Mark Tamar, I'm excited to be talking with you about Symptomatic.
- 43:29Speaker 3: Lauren Bright Pachaco is the host of Symptomatic. She is brilliant,
- 43:34Speaker 3: she's a journalist, she's a storyteller. This is a medical
- 43:38Speaker 3: mystery podcast. We can't wait to share this with you.
- 43:41Speaker 3: We can't wait to tell you what's coming down the
- 43:44Speaker 3: pike for the transformation of the pharmacist independent community pharmacy.
- 43:49Speaker 3: We can't wait to tell you what's happening in specialty pharmacy,
- 43:53Speaker 3: infusion pharmacy. We cannot wait to share of the political
- 43:58Speaker 3: impacts that fire sister making. All of this programming is
- 44:02Speaker 3: coming actually before the end of the year, so hang on.
- 44:06Speaker 2: There's going to be a.
- 44:07Speaker 3: Lot happening here in Pharmacy podcast network land. We want
- 44:11Speaker 3: to share it with you. We also want to shout
- 44:13Speaker 3: out if you want to be a part of it.
- 44:15Speaker 2: You be a part of it.
- 44:16Speaker 3: You come Aboard. You be a part of this. This
- 44:18Speaker 3: is how we're growing. Let us know how we're doing.
- 44:22Speaker 3: Subscribe on all podcast platforms. Please share the podcast links.
- 44:29Speaker 3: Know that we're going to be expanding content in many ways.
- 44:32Speaker 3: But if you have an interest in expertise, reach out
- 44:36Speaker 3: to me. Hey, you have a great week and we'll
- 44:39Speaker 3: talk to you next time.
- 44:40Speaker 2: On This Week in Pharmacy,